C7912
Cefotaxime sodium salt
potency: 916-964 μg per mg
Manufacturer: Sigma Aldrich
CAS Number: 64485-93-4
Synonym(S): Cefotaxime, Cefotaxim sodium salt
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 G | C7912-1-G | In Stock | ₹ 22,234.55 |
| 5 G | C7912-5-G | In Stock | ₹ 76,586.88 |
C7912 - 1 G
In Stock
Quantity
1
Base Price: ₹ 22,234.55
GST (18%): ₹ 4,002.219
Total Price: ₹ 26,236.769
form
powder
Quality Level
200
potency
916-964 μg per mg
solubility
H2O: 50 mg/mL
antibiotic activity spectrum
Gram-negative bacteriaGram-positive bacteria
Mode of action
cell wall synthesis | interferes
storage temp.
2-8°C
SMILES string
[Na+].[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\c3csc(N)n3)C([O-])=O
InChI
1S/C16H17N5O7S2.Na/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8;/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26);/q;+1/p-1/b20-9-;/t10-,14-;/m1./s1
InChI key
AZZMGZXNTDTSME-JUZDKLSSSA-M
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | TOKU-E Cefotaxime Sodium, USP, 64485-93-4, 1 g | TOKU-E | ₹ 9,497.16 | |
 | TOKU-E Cefotaxime Sodium, USP, 64485-93-4, 1 g | TOKU-E | ₹ 40,555.44 | |
 | Sigma Aldrich Fine Chemicals Biosciences Cefotaxime Sodium Salt | 64485-93-4 | MFCD00079073 | 1g | Sigma Aldrich Fine Chemicals Biosciences | ₹ 31,233.68 | |
 | Cefotaxime Sodium | Supelco | ₹ 16,616.38 | |
| | Cefotaxime sodium | Sigma Aldrich | ₹ 46,222.75 | |
| | Cefotaxime sodium | Sigma Aldrich | ₹ 16,107.60 | |
| | Cefotaxime for peak identification | Sigma Aldrich | ₹ 14,267.35 | |
| | Cefotaxime sodium salt | Sigma Aldrich | ₹ 6,170.25 - ₹ 1,90,649.90 | |
| | Cefotaxime sodium salt | Sigma Aldrich | ₹ 22,234.55 - ₹ 76,586.88 | |
 | 64485-93-4 | sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | A2B Chem | ₹ 1,454.52 - ₹ 56,555.16 |
Related Products
Description
- General description: Chemical structure: ß-lactam
- Application: Cefotaxim has been used to find new residues involved in cefotaxime hydrolysis in CTX-M β-lactamases,[1] to study antibiotic-susceptible and -resistant Streptococcus pneumoniae infections,[2] and to study pneumococcal pneumonia and the pharmokinetics of various treatments.[3] It may be used to study the effects of binding and inhibition of penicillin binding protein 2 (PBP2) on bacterial mucopeptide synthesis.
- Biochem/physiol Actions: Cefotaxim inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls. As a result, bacteria lyse due to cell wall autolytic enzymes.
- Other Notes: Broad spectrum third generation cephalosporin antibiotic.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Resp. Sens. 1 - Skin Sens. 1
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Compare Similar Items
Show Difference
form: powder
Quality Level: 200
potency: 916-964 μg per mg
solubility: H2O: 50 mg/mL
antibiotic activity spectrum: Gram-negative bacteriaGram-positive bacteria
Mode of action: cell wall synthesis | interferes
storage temp.: 2-8°C
SMILES string: [Na+].[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\c3csc(N)n3)C([O-])=O
InChI: 1S/C16H17N5O7S2.Na/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8;/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26);/q;+1/p-1/b20-9-;/t10-,14-;/m1./s1
InChI key: AZZMGZXNTDTSME-JUZDKLSSSA-M
form:
powder
Quality Level:
200
potency:
916-964 μg per mg
solubility:
H2O: 50 mg/mL
antibiotic activity spectrum:
Gram-negative bacteriaGram-positive bacteria
Mode of action:
cell wall synthesis | interferes
storage temp.:
2-8°C
SMILES string:
[Na+].[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\c3csc(N)n3)C([O-])=O
InChI:
1S/C16H17N5O7S2.Na/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8;/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26);/q;+1/p-1/b20-9-;/t10-,14-;/m1./s1
InChI key:
AZZMGZXNTDTSME-JUZDKLSSSA-M
form: powder
Quality Level: 200
potency: __
solubility: __
antibiotic activity spectrum: __
Mode of action: __
storage temp.: −20°C
SMILES string: __
InChI: __
InChI key: __
form:
powder
Quality Level:
200
potency:
__
solubility:
__
antibiotic activity spectrum:
__
Mode of action:
__
storage temp.:
−20°C
SMILES string:
__
InChI:
__
InChI key:
__
form: __
Quality Level: __
potency: __
solubility: __
antibiotic activity spectrum: __
Mode of action: __
storage temp.: __
SMILES string: __
InChI: __
InChI key: __
form:
__
Quality Level:
__
potency:
__
solubility:
__
antibiotic activity spectrum:
__
Mode of action:
__
storage temp.:
__
SMILES string:
__
InChI:
__
InChI key:
__
form: powder
Quality Level: 100
potency: __
solubility: __
antibiotic activity spectrum: __
Mode of action: __
storage temp.: __
SMILES string: CCCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@]2(C)C3CC[C@]4(C)C(CCC4C3CC=C2C1)[C@H](C)CCCC(C)C
InChI: 1S/C45H80O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-43(46)47-38-30-32-44(5)37(34-38)26-27-39-41-29-28-40(36(4)24-22-23-35(2)3)45(41,6)33-31-42(39)44/h26,35-36,38-42H,7-25,27-34H2,1-6H3/t36-,38+,39+,40-,41+,42+,44+,45-/m1/s1
InChI key: XHRPOTDGOASDJS-XNTGVSEISA-N
form:
powder
Quality Level:
100
potency:
__
solubility:
__
antibiotic activity spectrum:
__
Mode of action:
__
storage temp.:
__
SMILES string:
CCCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@]2(C)C3CC[C@]4(C)C(CCC4C3CC=C2C1)[C@H](C)CCCC(C)C
InChI:
1S/C45H80O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-43(46)47-38-30-32-44(5)37(34-38)26-27-39-41-29-28-40(36(4)24-22-23-35(2)3)45(41,6)33-31-42(39)44/h26,35-36,38-42H,7-25,27-34H2,1-6H3/t36-,38+,39+,40-,41+,42+,44+,45-/m1/s1
InChI key:
XHRPOTDGOASDJS-XNTGVSEISA-N